SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-gamma and IL-4 signaling in vivo
about
Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiationNegative regulation of cytokine signaling and immune responses by SOCS proteinsAn alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cells.Hepatitis C virus infection and type 1 and type 2 diabetes mellitusModulation of NKT cell development by B7-CD28 interaction: an expanding horizon for costimulation.Involvement of IL-18 in the expansion of unique hepatic T cells with unconventional cytokine profiles during Schistosoma mansoni infection.Microbiota-liver axis in hepatic disease.Polycystic kidneys and chronic inflammatory lesions are the delayed consequences of loss of the suppressor of cytokine signaling-1 (SOCS-1).SOCS1, a Negative Regulator of Cytokine Signals and TLR Responses, in Human Liver Diseases.Suppressor of cytokine signaling-1 selectively inhibits LPS-induced IL-6 production by regulating JAK-STATCrowding-dependent production of colony-stimulating factors by cultured syngeneic or allogeneic hematopoietic cellsImmunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myelomaThe paradigm of IL-6: from basic science to medicineSuppressor of cytokine signaling 1 (SOCS1) mitigates anterior uveitis and confers protection against ocular HSV-1 infectionOpposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.Unique T cells with unconventional cytokine profiles induced in the livers of mice during Schistosoma mansoni infection.Severe pancreatitis with exocrine destruction and increased islet neogenesis in mice with suppressor of cytokine signaling-1 deficiency.Innate self recognition by an invariant, rearranged T-cell receptor and its immune consequences.The lethal effects of transplantation of Socs1-/- bone marrow cells into irradiated adult syngeneic recipientsA SOCS-1 promoter variant is associated with total serum IgE levels.Suppressor of cytokine signaling-1 (SOCS1) inhibits lymphocyte recruitment into the retina and protects SOCS1 transgenic rats and mice from ocular inflammation.Differential expression of suppressor of cytokine signalling proteins in Behçet's disease.Increased nuclear suppressor of cytokine signaling 1 in asthmatic bronchial epithelium suppresses rhinovirus induction of innate interferonsSuppressor of cytokine signalling 1 (SOCS1) is a physiological regulator of the asthma responseFrom cellular receptors to transduction-transcription pathways for cytokines: at which level should the inhibition be targeted in inflammation?SOCS1: a potent and multifaceted regulator of cytokines and cell-mediated inflammation.SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesisSOCS-1 regulates IL-15-driven homeostatic proliferation of antigen-naive CD8 T cells, limiting their autoimmune potential.Suppressor of cytokine signaling 1 inhibition strategy to enhance anti-HIV vaccination.Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell lineSOCS1 regulates CCR7 expression and migration of CD4+ T cells into peripheral tissuesSOCS regulation of the JAK/STAT signalling pathway.Control of T helper cell differentiation through cytokine receptor inclusion in the immunological synapse.Suppression of cytokine signaling: the SOCS perspective.JUNB/AP-1 controls IFN-γ during inflammatory liver disease.Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases.Nuclear Localization of Suppressor of Cytokine Signaling-1 Regulates Local Immunity in the Lung.STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line.T-helper cell-mediated factors in drug-induced liver injury.Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity.
P2860
Q24538645-E5247054-2741-4014-BF32-09F8CFE4C16DQ24816896-0A4893EC-3DFD-4510-904A-E440AEF8A44CQ25256583-6766F5E1-E97A-4CBD-BFEC-81F9D546EE29Q26829202-C34A131C-F6EE-413F-85DD-FA0F67B4EE88Q30845162-BAE3C4A6-E94C-4A04-B1B1-C0EADE512A3AQ33604497-5F164969-04D1-4EE9-AEAA-08325E2223B4Q33855414-1282A0B8-C1D4-4918-ACCE-0F7C37DE5EE9Q33894724-9E3AEBFD-D5ED-4F15-8CDF-321E68B127BFQ34127568-D13833F3-3378-4227-BBEE-83DFA4A22D30Q34144743-53CE2EC5-F4E3-4FDA-B5D2-9103D7B2B4E6Q34330124-C475D151-D536-4465-A8C4-F8B73B03C3BAQ34369823-682A7929-3E55-404B-A511-91F773A14051Q34731226-26881D22-DC04-4B8E-B1E0-DA639F06E07AQ34810532-8BF93DB9-112C-4A34-9F7B-59C1ABD3B31CQ34826141-F64B1DFB-ACA0-42ED-8FD5-3372EAB9024AQ35072871-8282D989-DB1D-4529-9FA4-884C0CE8B28BQ35103140-F57B2EDC-99AF-45DE-BB84-336558D7D5DFQ35131643-89FBE4CC-7C60-487C-A629-81B95A622AEEQ35168328-74378718-2F0C-417D-BBDD-518E316FC904Q35175588-3F9A5BD5-03F2-4C4C-AA41-E8CDD030DFB9Q35221160-134D9C5E-24A3-4950-9CEE-C336EB6F6C95Q35245711-4C7D185E-F01E-4AC2-9463-E250F380C412Q35971340-3E20D263-52F1-4251-9ADA-6AD36969D7FBQ36253193-DEEC3187-AD2F-40BB-BA86-ADD1386DE807Q36269632-1A191150-C3E0-4F82-B65D-8FC6974BE0C1Q36383865-206FE0D2-8DAA-4C8F-991C-8A44161B09FAQ36402678-8E17A139-3CB7-4233-86AF-58B336475886Q36403649-C11A85AC-B297-4F37-8A42-4458CC37BFFBQ36600347-8896901C-5C81-40BA-BB5C-EA247BE3993BQ36695660-F9EF72F6-E3D9-4C2B-BF9F-D5B4B89B74F4Q36874342-22407E13-2795-4F57-8B92-908B922CC61CQ37003892-2194999D-B61F-4AA1-A84D-5B69B4B25105Q37273309-298677C3-FCAB-470B-BD04-6167C514A142Q37278469-0637E73D-7EEB-47BF-8ABE-E82A5782119EQ37384060-48993AE9-D010-4ACF-B7E8-5DCE4F4B2CFDQ37414046-E24F9A10-E9FD-4010-B14B-19D02685120EQ37421222-CDCF6931-29C2-48E2-BE37-21B18F2BD706Q38354113-8763226B-739A-4154-8E93-F98CF9691E41Q38370632-778405AF-3E84-4542-8426-D8DCF6AFE690Q40488939-ED046C5A-67FD-47F5-9176-00C434985459
P2860
SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-gamma and IL-4 signaling in vivo
description
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2001
@ast
im Mai 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2001/05/01)
@sk
vědecký článek publikovaný v roce 2001
@cs
wetenschappelijk artikel (gepubliceerd op 2001/05/01)
@nl
наукова стаття, опублікована в травні 2001
@uk
مقالة علمية (نشرت في مايو 2001)
@ar
name
SOCS-1/SSI-1-deficient NKT cel ...... mma and IL-4 signaling in vivo
@ast
SOCS-1/SSI-1-deficient NKT cel ...... mma and IL-4 signaling in vivo
@en
SOCS-1/SSI-1-deficient NKT cel ...... mma and IL-4 signaling in vivo
@nl
type
label
SOCS-1/SSI-1-deficient NKT cel ...... mma and IL-4 signaling in vivo
@ast
SOCS-1/SSI-1-deficient NKT cel ...... mma and IL-4 signaling in vivo
@en
SOCS-1/SSI-1-deficient NKT cel ...... mma and IL-4 signaling in vivo
@nl
prefLabel
SOCS-1/SSI-1-deficient NKT cel ...... mma and IL-4 signaling in vivo
@ast
SOCS-1/SSI-1-deficient NKT cel ...... mma and IL-4 signaling in vivo
@en
SOCS-1/SSI-1-deficient NKT cel ...... mma and IL-4 signaling in vivo
@nl
P2093
P1433
P1476
SOCS-1/SSI-1-deficient NKT cel ...... mma and IL-4 signaling in vivo
@en
P2093
H. Kohzaki
H. Tsutsui
K. Nakanishi
M. Fujimoto
M. Narazaki
R. Nakagawa
T. Kishimoto
T. Yoshimoto
P304
P356
10.1016/S1074-7613(01)00132-7
P407
P577
2001-05-01T00:00:00Z